Kimberly-Clark Shares Rise Amid Positive Developments
Kimberly-Clark shares have surged nearly 8% this week, marking their best performance in four years and placing the stock at the top of a portfolio leaderboard. The rally follows better-than-feared preliminary third-quarter results released on Thursday, regulatory approvals for its pending acquisition of Kenvue, and clarification from Chinese authorities that Huggies diapers do not contain toxic formamide. The company reported preliminary revenue of $4.13 billion and earnings per share (EPS) of $1.70 in the three months ended September 2024—both exceeding Wall Street estimates. The results came after a challenging period, including a nearly 9.8% drop in September due to weaker-than-expected guidance at an industry conference. The stock's recent strength is also attributed to broader market shifts toward defensive sectors like consumer staples amid volatility in the AI trade. Analysts and investors are optimistic about the Kenvue acquisition as it adds a fundamental catalyst for growth.
Topics: Consumer Staples Kenvue Acquisition Kimberly-Clark Regulatory Approvals Stock Price Movement
Part of the story Kimberly-Clark Shares Rise Amid Positive Developments (4 articles)